Executive Briefing Series (formerly The Food & Drug Letter)
Oct. 5, 2012
FDA: Submit Launch Promotions Early for Accelerated Approval Drugs
Drugmakers with drugs or biologics under FDA review for accelerated approval should submit promotional materials to the agency while the drug is under review if they plan to use the launch materials within 120 days of approval.
This article is viewable by subscribers only. To view this article, please select an option below.